Effect of lidocaine delivered by a hand-held metered-dose inhaler on steroid-resistant asthma

K. Yin, X. Zhang (Nanjing, China)

Source: Annual Congress 2005 - Treatment options for moderate and severe asthma
Session: Treatment options for moderate and severe asthma
Session type: Thematic Poster Session
Number: 425
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Yin, X. Zhang (Nanjing, China). Effect of lidocaine delivered by a hand-held metered-dose inhaler on steroid-resistant asthma. Eur Respir J 2005; 26: Suppl. 49, 425

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 209s
Year: 2006

Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010

Efficiency of ipratropium bromide and salbutamol deposition in the lung delivered via a soft-spray inhaler or chlorofluorocarbon metered-dose inhaler
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011


Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
Source: Eur Respir J 2002; 19: 246-251
Year: 2002



Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Oral manifestations in asthmatic patients using metered dose inhaler and dry powder inhaler
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 429s
Year: 2002

Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005



The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique
Source: Virtual Congress 2020 – How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go?
Year: 2020




Systemic effects and pharmacokinetics of a new CFC-free metered dose inhaler of beclomethasone dipropionate following multiple dosing in asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 180s
Year: 2005

Salmeterol metered dose inhaler (MDI) propelled by hydrofluoroalkane (HFA) is non-inferior to salmeterol chlorofluorocarbon (CFC) propelled MDI in paediatic patients with persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 583s
Year: 2004

Improved delivery of fenoterol plus ipratropium bromide using Respimat(R) compared with a conventional metered dose inhaler
Source: Eur Respir J 2001; 17: 225-232
Year: 2001



Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Comparison of HFA fluticasone-formoterol combination pressurized meter dose inhaler (pMDI) and HFA budesonide-formoterol combination pMDI in patients with moderate to severe persistent asthma
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010


Preference for novel soft mist inhaler over pMDI in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 88s
Year: 2004

Formoterol via turbuhaler (F) versus salbutamol via pressurized metered-dose inhaler (SB) in acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020